Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study

ConclusionBatoclimab is effective and safe in Chinese patients with gMG.Trial RegistrationThis study was registered at ClinicalTrials.gov (NCT04346888) on 15 April 2020, with the first patient enrolled on 23 July 2020.
Source: Neurology and Therapy - Category: Neurology Source Type: research